Summary
In a major pharmaceutical case, on remand Delaware Chancery finds plaintiff proved it had a reasonable expectation of profits at the time of breach; court accepts plaintiff expert’s damages model, but orders adjustments, particularly to sales quantity.
PharmAthene, Inc. v. SIGA Technologies, Inc.
PDF, Size: 448 KB
See Also
Chancery’s Reversal on Damages Opinion Bodes Well for Plaintiff
In a major pharmaceutical case, on remand Delaware Chancery finds plaintiff proved it had a reasonable expectation of profits at the time of breach; court accepts plaintiff expert’s damages model, but orders adjustments, particularly to sales quantity.